207 related articles for article (PubMed ID: 31102316)
1. Hyaluronic acid synthase 2 promotes malignant phenotypes of colorectal cancer cells through transforming growth factor beta signaling.
Kim YH; Lee SB; Shim S; Kim A; Park JH; Jang WS; Lee SJ; Myung JK; Park S; Lee SJ; Kim MJ
Cancer Sci; 2019 Jul; 110(7):2226-2236. PubMed ID: 31102316
[TBL] [Abstract][Full Text] [Related]
2. Has2 natural antisense RNA and Hmga2 promote Has2 expression during TGFβ-induced EMT in breast cancer.
Kolliopoulos C; Lin CY; Heldin CH; Moustakas A; Heldin P
Matrix Biol; 2019 Jul; 80():29-45. PubMed ID: 30194979
[TBL] [Abstract][Full Text] [Related]
3. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
[TBL] [Abstract][Full Text] [Related]
4. Hyaluronan synthase 2 (HAS2) regulates cell phenotype and invadopodia formation in luminal-like breast cancer cells.
Sheng Y; Cao M; Liu Y; He Y; Zhang G; Du Y; Gao F; Yang C
Mol Cell Biochem; 2021 Sep; 476(9):3383-3391. PubMed ID: 33954907
[TBL] [Abstract][Full Text] [Related]
5. Hyaluronan synthase 2 expressed by cancer-associated fibroblasts promotes oral cancer invasion.
Zhang Z; Tao D; Zhang P; Liu X; Zhang Y; Cheng J; Yuan H; Liu L; Jiang H
J Exp Clin Cancer Res; 2016 Nov; 35(1):181. PubMed ID: 27884164
[TBL] [Abstract][Full Text] [Related]
6. Silencing of lncRNA EZR-AS1 inhibits proliferation, invasion, and migration of colorectal cancer cells through blocking transforming growth factor β signaling.
Liu Z; Wang N; Wang F; Zhang S; Ding J
Biosci Rep; 2019 Nov; 39(11):. PubMed ID: 31693738
[TBL] [Abstract][Full Text] [Related]
7. LncRNA SNHG6 promotes proliferation, invasion and migration in colorectal cancer cells by activating TGF-β/Smad signaling pathway via targeting UPF1 and inducing EMT via regulation of ZEB1.
Wang X; Lai Q; He J; Li Q; Ding J; Lan Z; Gu C; Yan Q; Fang Y; Zhao X; Liu S
Int J Med Sci; 2019; 16(1):51-59. PubMed ID: 30662328
[No Abstract] [Full Text] [Related]
8. Knockdown of TMEM45A overcomes multidrug resistance and epithelial-mesenchymal transition in human colorectal cancer cells through inhibition of TGF-β signalling pathway.
Zhu M; Jiang B; Yan D; Wang X; Ge H; Sun Y
Clin Exp Pharmacol Physiol; 2020 Mar; 47(3):503-516. PubMed ID: 31788833
[TBL] [Abstract][Full Text] [Related]
9. DcR3 induces epithelial-mesenchymal transition through activation of the TGF-β3/SMAD signaling pathway in CRC.
Liu YP; Zhu HF; Liu DL; Hu ZY; Li SN; Kan HP; Wang XY; Li ZG
Oncotarget; 2016 Nov; 7(47):77306-77318. PubMed ID: 27764793
[TBL] [Abstract][Full Text] [Related]
10. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
[TBL] [Abstract][Full Text] [Related]
11. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
[TBL] [Abstract][Full Text] [Related]
12. Transcription factor POU4F2 promotes colorectal cancer cell migration and invasion through hedgehog-mediated epithelial-mesenchymal transition.
Guo K; Wang P; Zhang L; Zhou Y; Dai X; Yan Y; Chen Y; Wasan HS; Yu J; Ruan S; Sun L
Cancer Sci; 2021 Oct; 112(10):4176-4186. PubMed ID: 34327778
[TBL] [Abstract][Full Text] [Related]
13. Excessive hyaluronan production promotes acquisition of cancer stem cell signatures through the coordinated regulation of Twist and the transforming growth factor β (TGF-β)-Snail signaling axis.
Chanmee T; Ontong P; Mochizuki N; Kongtawelert P; Konno K; Itano N
J Biol Chem; 2014 Sep; 289(38):26038-26056. PubMed ID: 25077968
[TBL] [Abstract][Full Text] [Related]
14. USP22 drives colorectal cancer invasion and metastasis via epithelial-mesenchymal transition by activating AP4.
Li Y; Yang Y; Li J; Liu H; Chen F; Li B; Cui B; Liu Y
Oncotarget; 2017 May; 8(20):32683-32695. PubMed ID: 28427243
[TBL] [Abstract][Full Text] [Related]
15. PDGF-D promotes cell growth, aggressiveness, angiogenesis and EMT transformation of colorectal cancer by activation of Notch1/Twist1 pathway.
Chen J; Yuan W; Wu L; Tang Q; Xia Q; Ji J; Liu Z; Ma Z; Zhou Z; Cheng Y; Shu X
Oncotarget; 2017 Feb; 8(6):9961-9973. PubMed ID: 28035069
[TBL] [Abstract][Full Text] [Related]
16. MiR-148a suppressed cell invasion and migration via targeting WNT10b and modulating β-catenin signaling in cisplatin-resistant colorectal cancer cells.
Shi L; Xi J; Xu X; Peng B; Zhang B
Biomed Pharmacother; 2019 Jan; 109():902-909. PubMed ID: 30551544
[TBL] [Abstract][Full Text] [Related]
17. LncRNA CHRF-induced miR-489 loss promotes metastasis of colorectal cancer via TWIST1/EMT signaling pathway.
Tao Y; Han T; Zhang T; Ma C; Sun C
Oncotarget; 2017 May; 8(22):36410-36422. PubMed ID: 28430582
[TBL] [Abstract][Full Text] [Related]
18. HLTF suppresses the migration and invasion of colorectal cancer cells via TGF‑β/SMAD signaling in vitro.
Liu L; Liu H; Zhou Y; He J; Liu Q; Wang J; Zeng M; Yuan D; Tan F; Zhou Y; Pei H; Zhu H
Int J Oncol; 2018 Dec; 53(6):2780-2788. PubMed ID: 30320371
[TBL] [Abstract][Full Text] [Related]
19. TGFβ1I1 suppressed cell migration and invasion in colorectal cancer by inhibiting the TGF-β pathway and EMT progress.
Ruan XJ; Ye BL; Zheng ZH; Li ST; Zheng XF; Zhang SZ
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7294-7302. PubMed ID: 32706067
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of long non-coding RNA-CTD903 inhibits colorectal cancer invasion and migration by repressing Wnt/β-catenin signaling and predicts favorable prognosis.
Yuan Z; Yu X; Ni B; Chen D; Yang Z; Huang J; Wang J; Chen D; Wang L
Int J Oncol; 2016 Jun; 48(6):2675-85. PubMed ID: 27035092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
